主动输液实践模式在肿瘤中晚期患者中药治疗中的应用  

Application of active infusion practice mode in the traditional Chinese treatment of middle and advanced tumor patients

作　　者：张志敏 贾丽魏 许璐[1] 谭荣新 Zhang Zhimin;Jia Liwei;Xu Lu;Tan Rongxin

机构地区：[1]解放军总医院第六医学中心,北京100048

出　　处：《中医临床研究》2020年第3期87-88,共2页Clinical Journal Of Chinese Medicine

基　　金：国家自然科学基金资助项目(81660773);甘肃省中医药课题资助项目(GZK-2018-15);敦煌医学与转化教育部重点实验室开放基金项目(DHYX18-19)。

摘　　要：目的:探讨主动输液模式对中晚期肿瘤患者中药抗肿瘤治疗输液并发症的影响。方法:对比分析2017年8月-2019年9月解放军总医院第六医学中心收治的183例中晚期肿瘤患者,接受中药抗肿瘤治疗时,对比不同静脉通路下输液并发症的发生率。结果:输液方式选择中心静脉置管的患者,静脉炎和药物外渗的发生率明显低于选择外周静脉通路的患者,差异有统计学意义(P<0.01)。结论:实施主动输液模式能降低输液并发症的发生,保证中晚期肿瘤患者的中药治疗安全,值得临床应用。Objective:To investigate the effect of active infusion mode on the complications of TCM antitumor infusion in patients with middle and advanced tumor.Methods:A comparative analysis was made of 183 patients with middle and advanced tumors admitted to our department from August 2017 to September 2019,and the incidence of infusion complications under different venous access was compared when receiving traditional Chinese medicine anti-tumor treatment.Results:The occurrence of complications,phlebitis and vascular extravasation,in patients via PICC mode were significantly lower than those in patients via peripheral venous transfusion mode(P<0.01).Conclusion:The implementation of the active infusion mode can reduce the occurrence of infusion complications and ensure the safety of traditional Chinese medicine treatment for patients with middle and advanced tumors,which is worthy of clinical application.

关 键 词：主动输液实践模式 中药抗肿瘤治疗 并发症 

分 类 号：R472[医药卫生—护理学]